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Abstract
Objective—Obesity is an important risk factor for colorectal neoplasia; however, little research 
exists on racial differences in obesity measures (BMI, waist circumference (WC), and waist-hip-
ratio (WHR)) associated with adenoma.
Design and Methods—We used data from the Diet and Health Studies, Phases III-V to 
examine differences in the contribution of obesity measures to adenoma risk by race. The sample 
consisted of 2,184 patients (1,806 white, 378 African American) undergoing outpatient 
colonoscopy for average risk screening. Covariates included demographics, health history, and 
validated measures of diet and physical activity.
Results—Among whites, BMI (Overweight: OR 1.31, 95% CI 1.00—1.71; Obese: OR 1.89, 
95% CI 1.41—2.56), WC (OR 1.47, 95% CI 1.09—1.99), and WHR (OR 1.60 95% CI 1.24—
2.06) were associated with adenomas. BMI was not associated with adenomas in African 
Americans. Although the confidence intervals were wide, the point estimates for WHR (OR 1.07, 
95% CI 0.51—2.22) and WC (OR 1.04, 95% CI 0.56—1.92) were slightly elevated above the null.
Conclusions—BMI was associated with adenomas only among whites, whereas WHR and WC 
appeared to be important risk factors among both races. Racial differences in adenoma risk may be 
due to differences in body shape and weight and/or fat distribution.
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Introduction
Obesity has been consistently associated with an increased risk of colorectal cancer (CRC). 
Several meta-analyses indicate common clinical measures of obesity, including body mass 
index (BMI), waist circumference (WC), and waist-hip-ratio (WHR), are positively 
associated with CRC in both men and women (1, 2).
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Epidemiologic studies also suggest measures of obesity are associated with an increased risk 
of colorectal adenomas, the precursor to most CRCs. Results from studies of body size and 
adenoma risk vary with respect to which obesity measure was used (e.g., BMI, WC, WHR), 
as well as by sex (3–7). However, a recent meta-analysis (8) reported the highest levels of 
WC and WHR independently contributed to an increased risk for adenomas. Similarly, a 
meta-analysis (9) that examined the relationship between BMI and adenomas suggested a 5-
unit increase in BMI is associated with an increased risk for adenomas. The findings from 
both studies were independent of age, sex, and geographic location.
Although obesity has been established as an important risk factor for colorectal adenomas, 
we lack sufficient data on which clinical measures of obesity are most relevant to the 
development of adenomas in different racial populations. It is well understood that CRC 
incidence and mortality differ by race and ethnicity, but few studies have examined potential 
differences in how obesity measures relate to cancer risk by race. Further, there has been 
little research on the racial differences in the association of various obesity measures with 
colorectal adenomas. Many existing studies have utilized predominantly white-American or 
European samples, which may limit generalizability, and few studies have examined obesity 
measures in the context of other known adenoma risk factors (e.g., diet, family history, 
smoking). It is important to use the most relevant measure of obesity in specific racial 
populations to adequately characterize cancer risk. Therefore, we examined the racial 
differences in the relationship between obesity measures (BMI, WC, and WHR) and 
colorectal adenomas in a large, diverse screening population.
Methods
Participants and Procedures
We used data from the University of North Carolina Diet and Health Studies (DHS), Phases 
III-V to determine the association of different obesity measures with colorectal adenoma by 
race. The design and methods of the studies have been described in detail elsewhere (10, 
11). Briefly, DHS were cross-sectional studies that examined environmental and lifestyle 
factors associated with presence of colorectal adenomas. Patients undergoing an outpatient 
colonoscopy in 1998—2010 (DHS III: 1998–2000; DHS IV: 2001–2001; DHS V: 2009–
2010) at the University of North Carolina Hospitals (Chapel Hill, NC) were recruited to 
participate. The most common indication for colonoscopy was average risk CRC screening. 
Eligible patients were between the ages of 30—80 years, had satisfactory preparation for the 
colonoscopy with complete examination to the cecum, and gave informed consent. Patients 
with a previous history of colon resection or diagnosis of polyposis, colitis, or CRC were 
excluded. For the purposes of this analysis, we further excluded any patient who reported a 
race/ethnicity other than white or African American (n=274).
Measures
Outcome Variable—Presence of any adenoma on the colonoscopy report was assessed as 
the binary dependent variable.
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Obesity Measures—A trained research assistant measured height, weight, and waist and 
hip circumference at the time of colonoscopy. BMI was measured as kg/m2 and categorized 
according to standard cutpoints: normal (18.5–25), overweight (≥25–30), and obese (>30). 
Waist circumference was measured at the narrowest part of the torso, and hip circumference 
was measured at the level of greatest lateral extension of the hips (both in cm). WHR was 
calculated as the ratio of waist and hip circumference. In accordance with WHO standards, 
high WHR was defined as greater than 0.9 and 0.8 for men and women, respectively. Waist 
circumference above 102 cm in men and 88 cm in women was considered high (12).
Covariates—Age, sex, race, health history, and lifestyle factors were examined as 
covariates. Race was self-reported by study participants.
Within 12 weeks of colonoscopy, participants were contacted by telephone to complete a 
questionnaire on lifestyle behaviors (e.g., diet, physical activity) and health history. 
Interviewers were blind to colonoscopy results. Dietary information was measured with the 
Block Diet History Questionnaire (DHS III) (13) and the National Cancer Institute Diet 
History Questionnaire (DHS IV-V) (14). Participants reported usual dietary habits (e.g., 
fiber, total fat, and red meat consumption) during the 1-year period preceding colonoscopy. 
Dietary measures were adjusted for total energy intake (15). Physical activity was assessed 
using a modified version of the Stanford 7-day physical activity recall (16) for participants 
in DHS III and IV. Physical activity in the DHS V was measured with the International 
Physical Activity Questionnaire (17). Because different physical activity measures were 
used across phases of DHS, raw metabolic equivalents (MET) were categorized into 
quartiles to allow comparison across all study participants (18).
Interviewers also collected information on participants’ family history of CRC (first-degree 
relative) and personal history of risk factors for CRC, including NSAID use, smoking, and 
alcohol use.
Data Analysis
Logistic regression models were used to examine the association between each obesity 
measure (BMI, WC, and WHR) and presence of colorectal adenomas. We examined 
differences in effect estimates across race/ethnicity by including a cross-product term of 
race/ethnicity and each obesity measure and calculating a p-value for heterogeneity using 
the -2-log likelihood statistic. Because the overall results suggested effect estimates varied 
across the two strata of race (p-value from likelihood ratio test: 0.003 (BMI), 0.02 (WC), 
0.16 (WHR)), subsequent analyses were stratified (white vs. African American).
We evaluated the potential for confounding by age, sex, smoking, alcohol use, NSAID use, 
diet (total energy, fat, and fiber intake, and red meat consumption), physical activity, and 
family history of CRC using a directed acyclic graph (DAG) to identify a minimally 
sufficient adjustment set of covariates (19–21). In addition to race/ethnicity, DAG analyses 
suggested the model be adjusted for sex, age, total fiber intake, total fat intake, red meat 
consumption, smoking, and physical activity. Unadjusted and adjusted associations between 
each measure of obesity and colorectal adenomas are reported as prevalence odds ratios and 
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95% confidence intervals. Participants with missing data on obesity measures and/or 
confounders included in the adjusted analysis were excluded.
To further examine the reasons for potential differences in adenoma risk by various obesity 
measures, we plotted BMI and WHR among whites and African Americans. We also 
examined the linear association between BMI and WHR in each racial group by calculating 
Pearson’s correlation coefficient.
Statistical analyses were conducted using Stata/1C, Version 13.0 (College Station, TX).
Results
The analysis included 2,184 participants. The mean age of study participants at the time of 
colonoscopy was 55.9 (SD 9.26). The majority were female (57.8%), and 17.3% (n=378) 
reported their race as African American. In total, 629 (29%) had one or more adenomas 
noted in their colonoscopy report and 1,555 (71%) had no adenomas. Characteristics of the 
study population by race and presence of adenomas are shown in Table 1.
The distribution of BMI, WHR, and WC was fairly similar among whites and African 
Americans (Table 2). Mean values in each strata of all obesity measures were generally 
comparable between the two races (p-value from test of equal means: normal BMI (0.14), 
overweight BMI (0.11), obese BMI (<0.01), normal WC (<0.01), high WC (<0.01), normal 
WHR (0.71), high WHR (0.09)), although there were some differences in WC. A greater 
proportion of African Americans had higher levels of BMI (49.4 vs. 22.2%, p <0.01), WHR 
(81.7 vs. 72.7%, p <0.01), and WC (70.0 vs. 47.9%, p<0.01).
Table 3 shows prevalence odds ratios for the association of obesity measures with colorectal 
adenomas. BMI, WHR, and WC elevated the odds of adenoma among whites (n=1,806). 
Within levels of BMI, we estimated crude odds ratios of 1.48 (95% CI 1.16—1.90) and 1.92 
(95% CI 1.46—2.51) for overweight and obese, respectively. The odds of adenoma were 
elevated among whites with high WHR (OR 1.96, 95% CI 1.49—2.59) and WC (OR 1.48, 
95% CI 1.18—1.86). Odds ratios from the model accounting for potential confounders were 
similar. Participants who were overweight (OR 1.31, 95% CI 1.00—1.71), obese (OR 1.89, 
95% CI 1.41—2.56), or had high WHR (OR 1.47, 95% CI 1.09—1.99) or WC (OR 1.60, 
95% CI 1.24—2.06) had higher odds of adenoma compared to those classified as normal. 
BMI and WHR were also correlated (r = 0.26) (Figure 1).
Among African Americans (n=378), the crude and adjusted odds ratios suggest BMI was not 
associated with adenomas (Table 3) (overweight: adjusted OR 0.98, 95% CI 0.48—1.99; 
obese: adjusted OR 0.67, 95% CI 0.35—1.30) Although the confidence intervals were wide, 
the WHR point estimates were elevated in the expected direction above the null (Crude: OR 
1.18, 95% CI 0.62—2.24; Adjusted: OR 1.07, 95% CI 0.51—2.22). Similarly, the adjusted 
odds ratio for the association between WC and adenoma was slightly elevated (OR 1.04, 
95% CI 0.56—1.92) but with a wider confidence interval (confidence limit ratio: 3.43). BMI 
and WHR were not correlated among African Americans (r = 0.07) (Figure 1).
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Our study provides new evidence that the most relevant measures of obesity with respect to 
colonic neoplasia may be different among races. The results highlight the importance of 
considering multiple obesity measures to assess adenoma and/or CRC risk in patients of 
different racial/ethnic backgrounds. We found that BMI was associated with adenomas only 
among whites, whereas WHR and WC appeared to be important risk factors among both 
whites and African Americans. The difference in the BMI-adenoma association between 
whites and African Americans may reflect differences in body composition. Researchers 
have hypothesized the variation in risk among obese individuals can be explained by 
variations in body composition and weight and/or fat distribution (22). In our study, the 
linear relationship between BMI and WHR (Figure 1) among whites could indicate greater 
levels of abdominal obesity in this subgroup. Our data suggest that higher-BMI whites tend 
to have more abdominally and/or centrally distributed fat (i.e., “apple” body shape), which 
may confer a greater risk for adenomas. BMI may be an important risk factor among whites 
because it is closely correlated with both WHR and WC.
Conversely, we did not observe a correlation between BMI and WHR in African Americans 
(Figure 1). Although a greater proportion of African Americans had a high WHR or WC, 
there was no relationship between BMI and WHR. This finding provides evidence that 
African Americans may have less abdominal fat and more fat around the hips (i.e., “pear” 
body shape). It could also explain why BMI was not associated with adenomas in the crude 
or adjusted analyses. Our data suggest BMI is not a useful measure of risk in African 
Americans because it does not adequately capture relevant patterns of abdominal obesity. 
Rather, measures of central obesity (e.g., WC and WHR) may be stronger indicators of risk. 
African Americans who have a body shape similar to whites (i.e., more abdominally 
distributed fat) may be at a higher risk for colorectal adenomas. In the future, researchers 
should examine the underlying differences in body composition and how these differences 
affect adenoma risk across racial/ethnic groups.
The differences we observed in adenoma risk may also be due to variations in visceral 
adipose tissue (VAT) among whites and African Americans. VAT is widely considered an 
important marker of health risk, with greater specificity than total fat mass or generalized 
obesity (23). Limited research suggests African Americans have consistently lower VAT 
compared to whites and/or Hispanics within similar WC and BMI strata (24). Others have 
reported whites exhibit higher levels of VAT than African Americans at higher levels of 
BMI, WC, and total body fat for both men and women (25, 26). Collectively, this research 
suggests the health hazards associated with obesity are differentially expressed through 
abdominal VAT. Our data support this view: African Americans had a lower risk of 
colorectal adenomas associated with BMI, which may reflect their lower abdominal VAT 
amounts. Further research is needed to determine whether different BMI cutoff points are 
necessary to adequately assess risk in different racial groups.
Our results also indicate that WHR and WC are better measures of central obesity than BMI, 
which is often poorly correlated with true body composition. A recent meta-analysis (27) of 
studies that assess the performance of BMI to detect body adiposity suggests BMI values 
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used to diagnose obesity have high specificity, but low sensitivity to identify adiposity, as 
they fail to identify the majority of individuals with excess body fat. This is consistent with 
our finding that WC and WHR were stronger measures of adenoma risk in both whites and 
African Americans. Alternative obesity measures, such as bioelectrical impedance analysis 
(BIA), may not be the best predictor of adenoma risk because it measures the total amount 
of fat but not the distribution (28). Other researchers have proposed the body adiposity index 
(BAI), calculated from hip circumference and height, as a better direct estimate of adiposity 
that can be easily implemented in clinical settings (29). While this measure may be 
encouraging, it has not been widely validated.
A strength of our study is the large, diverse screening population that comprised our sample. 
To date, the majority of studies of adenoma risk have been of predominantly white-
American or European populations. Few have included large samples of racial/ethnic 
minorities. Another strength is our use of reliable data on other established adenoma risk 
factors and validated measures of diet and physical activity (13, 14, 16, 17), which combine 
to limit the possibility of confounding bias or spurious results due to other important 
markers of adenoma risk.
Although our study is the largest to examine differences in obesity measures related to 
adenoma risk, the relatively small number of African Americans (compared to whites) may 
have contributed to the imprecision around the point estimates in this subgroup. Another 
potential limitation is measurement error from food frequency questionnaires and/or the 
different instruments used across DHS phases. However, we would not expect that diet 
would be differentially reported with respect to adenoma status. Finally, study participants 
with missing data were excluded from the analysis. Chi-square tests (all p<0.05) indicated 
that respondents with incomplete data (n=536, 25%) were more likely to be African 
American, male, and have higher BMI; however, there was no difference in the presence of 
adenoma on colonoscopy between participants with complete versus incomplete data. It is 
therefore unlikely that our results are overestimated associations.
In summary, our study provides further support for a relationship between obesity and risk 
of colorectal adenomas. In a large, diverse screening population, we found higher BMI, 
WHR, and WC were all important predictors of adenomas among whites, and a high WHR 
and WC elevated the likelihood of adenomas among African Americans. These findings are 
consistent with previous meta-analyses (8, 9) that suggest higher levels of WC and WHR, as 
well as increases in BMI, independently contribute to an increased risk for adenomas. The 
group-specific differences we observed in adenoma risk may be due to differences in body 
shape and/or distribution of fat. Our findings highlight the importance of using multiple 
obesity measures when assessing adenoma risk in patients of different racial/ethnic 
backgrounds. There has been some interest in developing risk prediction models based on 
adenoma risk factors that could be used to determine CRC screening intervals (30). 
Researchers have examined the utility of risk prediction models for advanced adenomas 
(31), and our results suggest race-specific risk factors may be necessary when developing 
future risk stratification tools. Using the most relevant measure of obesity is critical to 
adequately characterizing risk of adenomas and CRC in specific racial populations.
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Linear association between BMI and WHR among whites (n=1,806) and African Americans 
(n=374)
Abbreviations: BMI, body mass index; WHR, waist-hip-ratio
NOTE: Pearson’s correlation coefficient: 0.2587 (whites, p<0.05) and 0.0658 (African 
Americans, p not significant)
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Table 1
Characteristics of the study population by race and presence of adenoma (n=2,184)
Characteristic
Whites African-Americans
Adenoma (n=513) No Adenoma (n=1,293) Adenoma (n=116) No Adenoma (n=262)
Mean ± SD or n (%) Mean ± SD or n (%)
Age, y 58 ± 9.1 55 ± 9.1 59 ± 9.9 55 ± 9.2
Sex
 Male 281 (36.5) 490 (63.6) 55 (36.4) 96 (63.6)
 Female 232 (22.5) 801 (77.5) 61 (26.9) 166 (73.1)
BMI, kg/m2 28 ± 5.6 26 ± 5.4 31 ± 7.7 29 ± 6.7
 Normal (18.5–25) 169 (23.0) 567 (77.0) 28 (35.4) 51 (64.6)
 Overweight (≥25–30) 180 (30.7) 407 (69.3) 33 (34.7) 62 (65.3)
 Obese (>30) 139 (36.4) 243 (63.6) 45 (26.5) 125 (73.5)
WHR (continuous) 0.94 ± 0.087 0.91 ± 0.092 0.96 ± 0.087 0.93 ± 0.083
 Normal 80 (19.5) 330 (80.5) 16 (29.1) 39 (70.9)
 Higha 352 (32.3) 739 (67.7) 80 (32.7) 165 (67.4)
WC, cm (continuous) 100 (14.8) 94 (14.2) 104 (16.6) 103 (14.8)
 Normal 195 (24.9) 588 (75.1) 34 (34.7) 64 (65.3)
 Higha 237 (33.0) 482 (67.0) 62 (30.7) 140 (69.3)
Tobacco Useb, pack y 44 ± 40.3 35 ± 34.8 41 ± 33.6 40 ± 32.5
Smoking Status
 Never 251 (27.1) 675 (72.9) 60 (29.4) 144 (70.6)
 Former 196 (28.7) 486 (71.3) 31 (34.8) 58 (65.2)
 Current 63 (32.6) 130 (67.4) 24 (29.3) 59 (70.7)
Alcohol Usec, g/day 16 ± 43.3 12 ± 23.9 5 ± 7.1 6 ± 14.9
Regular NSAID Use (≥15/month) 148 (27.8) 385 (72.2) 25 (26.0) 69 (73.4)
Total Energy Intake, kcal/day 1907 ± 821.4 1821 ± 728.2 1666 ± 966.5 1792 ± 1037.3
Fat, g/day 73 ± 34.9 69 ± 32.1 67 ± 45.4 70 ± 42.8
Total Fiber, g/day 19 ± 8.9 20 ± 9.2 14 ± 10.0 16 ± 10.1
Red Meat, oz/day 3 ± 2.3 2 ± 2.0 3 ± 2.5 3 ± 2.3
Physical Activity, MET
 Quartile 1 134 (31.6) 290 (68.4) 45 (37.5) 75 (62.5)
 Quartile 2 131 (31.1) 290 (68.8) 18 (22.8) 61 (77.2)
 Quartile 3 92 (22.6) 315 (77.4) 14 (26.9) 38 (73.1)
 Quartile 4 110 (26.7) 302 (73.3) 26 (32.5) 54 (67.5)
Family History of CRC
 No 428 (28.6) 1067 (71.4) 93 (31.1) 206 (68.9)
 Yes 61 (27.1) 174 (72.9) 14 (29.2) 34 (70.8)
Abbreviations: y, years; BMI, body mass index; WHR, waist-hip ratio; WC, waist circumference; NSAID, nonsteroidal anti-inflammatory drug; 
MET, metabolic equivalent task; CRC, colorectal cancer
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NOTE: Raw METs were not equivalent between the two measures used to assess physical activity (see text for details). METs were categorized 
into quartiles based on the distribution in the control group. Missing values range from 0 (age) to 383 (WHR).
a
High WHR was defined as greater than 0.9 and 0.85 for men and women, respectively. Waist circumference above 102 cm in men and 88 cm in 
women was considered high (12).
b
Excludes participants who reported no history of tobacco use (n=1,130)
c
Excludes participants who reported no alcohol use (n=404)
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Table 3
Crude and adjusted prevalence odds ratios for colorectal adenomas among whites (n=1,806) and African 
Americans (n=378)
Whites (n=1,806) African Americans (n=378)
Crude OR (95% CI) Adjusteda OR (95% CI) Crude OR (95% CI) Adjusteda OR (95% CI)
BMI, kg/m2
 Normal (18.5–25) 1.00 (REF) 1.00 (REF) 1.00 (REF) 1.00 (REF)
 Overweight (25–30) 1.48 (1.16—1.90) 1.31 (1.00—1.71) 0.97 (0.52—1.81) 0.98 (0.48—1.99)
 Obese (>30) 1.92 (1.46—2.51) 1.89 (1.41—2.56) 0.66 (0.37—1.16) 0.67 (0.35—1.30)
WHR
 Normal 1.00 (REF) 1.00 (REF) 1.00 (REF) 1.00 (REF)
 Highb 1.96 (1.49—2.59) 1.47 (1.09—1.99) 1.18 (0.62—2.24) 1.07 (0.51—2.22)
WC
 Normal 1.00 (REF) 1.00 (REF) 1.00 (REF) 1.00 (REF)
 Highb 1.48 (1.18—1.86) 1.60 (1.24—2.06) 0.83 (0.50—1.39) 1.04 (0.56—1.92)
Abbreviations: OR, prevalence odds ratio; CI, confidence interval; BMI, body mass index; WHR, waist-hip ratio; WC, waist circumference; REF, 
referent
NOTE: Missing values ranged from 0 (age) to 383 (WHR). The adjusted model consists of 1,600 (BMI), 1,414 (WHR) 1,415 (WC) whites and 308 
(BMI), 269 (WHR), and 269 (WC) African Americans.
a
Adjusted for sex, smoking, age, physical activity, red meat consumption, total fat intake, and total fiber intake
b
High WHR was defined as greater than 0.9 and 0.85 for men and women, respectively. WC above 102 cm in men and 88 cm in women was 
considered high (12).
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